Isolating with physical restraint low status female monkeys during luteal phase might make an appropriate premenstrual depression syndrome model

Journal of Affective Disorders

Volumn 102, Issue 1-3, 2007, Pages 81-91

  Qiao, Mingqi ^a   Zhao, Qitao ^a   Zhang, Huiyun ^a   Wang, Haijun ^a   Xue, Ling ^a   Wei, Sheng ^a  

^a SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

5 hydroxytrypamine; Adrenalin; Macaque model; Noradrenalin; Premenstrual depression syndrome; Progesterone; Prolactin; Traditional Chinese medicine

Indexed keywords

ADRENALIN; HERBACEOUS AGENT; JINGQIANSHU GRANULE; MONOAMINE; NORADRENALIN; PROGESTERONE; PROLACTIN; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CAPILLARY ZONE ELECTROPHORESIS; CHINESE MEDICINE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; ESTRADIOL BLOOD LEVEL; FEMALE; HERBAL MEDICINE; LUTEAL PHASE; MENSTRUAL CYCLE; NEUROTRANSMISSION; NONHUMAN; PHYLOGENY; PHYSICAL ACTIVITY; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; RADIOIMMUNOASSAY; RHESUS MONKEY; SOCIAL ISOLATION; SOCIAL STATUS;

ANIMALS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, CAPILLARY; EPINEPHRINE; FEMALE; LUTEAL PHASE; MACACA MULATTA; NOREPINEPHRINE; PREMENSTRUAL SYNDROME; PROGESTERONE; PROLACTIN; RADIOIMMUNOASSAY; RANDOM ALLOCATION; RESTRAINT, PHYSICAL; SEROTONIN; SOCIAL BEHAVIOR;

EID: 34447286598     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.12.011     Document Type: Article

References (69)

1. Abbott D.H., Saltzman W., Schultz-Darken N.J., and Smith T.E. Specific neuroendocrine mechanisms not involving generalized stress mediate social regulation of female reproduction in cooperatively breeding marmoset monkeys. Ann. N.Y. Acad. Sci. 807 (1997) 219-238
2. Abbott D.H., Saltzman W., Schultz-Darken N.J., and Tannenbaum P.L. Adaptations to subordinate status in female marmoset monkeys. Comp. Biochem. Physiol. C 119 (1998) 261-274
3. Abbott D.H., Shu C., Foong Deborah K.B., Daniel A., and Dumesic. Nonhuman primates contribute unique understanding to anovulatory infertility in women. ILAR J. 45 2 (2004) 116-131
4. Adams M.R., Kaplan J.R., Clarkson T.B., and Koritnik D.R. Ovariectomy, social status, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis 5 (1985) 192-200
5. Andrus G.M. Recent and future advances in the treatment of PMS, PMD and menopause. IDrugs 4 12 (2001) 1373-1381
6. Appt S.E. Usefulness of the monkey model to investigate the role soy in postmenopausal women's health. ILAR J. 45 2 (2004) 200-211
7. Aujard F., Heistermann M., Thierry B., and Hodges J.K. Functional significance of behavioral, morphological, and endocrine correlates across the ovarian cycle in semifree ranging female Tonkean macaques. Am. J. Primatol. 46 4 (1998) 285-309
8. Barbara L., Parry R., Hauger, Betina L.V., Nasim M., Heidi C., Paul C.J., and Christian G. Circadian rhythms of prolactin and thyroid-stimulating hormone during the menstrual cycle and early versus late sleep deprivation in premenstrual dysphoric disorder. Psychiatry Res. 62 (1996) 147-160
9. Barnett D.K., and Abbott D.H. Reproductive adaptations to a large-brained fetus open a vulnerability to anovulation similar to polycystic ovary syndrome. Am. J. Human Biol. 15 (2003) 296-319
10. Berger D., Schaffner W., Schrader E., Meier B., and Brattstrom A. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Arch. Gynecol. Obstet. 264 3 (2000) 150-153 (Nov)
11. Bethea C.L., Streicher J.M., Mirkes S.J., Sanchez R.L., Reddy A.P., and Cameron J.L. Serotonin-related gene expression in female monkeys with individual sensitivity to stress. Neuroscience 132 1 (2005) 151-166
12. Blum I., Lerman M., Misrachi I., Nordenberg Y., Grosskopf I., Weizman A., Levy-Schiff R., Sulkes J., and Vered Y. Lack of plasma norepinephrine cyclicity, increased estradiol during the follicular phase, and of progesterone and gonadotrophins at ovulation in women with premenstrual syndrome. Neuropsychobiology 50 1 (2004) 10-15
13. Borodavka I.K. Relation of serum levels of serotonin and histamine and the presence of depressive syndrome in patients with duodenal ulcer. Klin. Med. (Mosk) 67 3 (1989) 102-104
14. Brown G.W., Harris T.O., and Eales M.J. Aetiology of anxiety and depressive disorders in an inner-city population 2. Co-morbidity and adversity. Psychol. Med. 23 (1993) 155-165
15. Brown G.W., Harris T.O., and Hepworth C. Life events and endogenous depression. A puzzle reexamined. Arch. Gen. Psychiatry 51 (1994) 523-534
16. Brown G.W., Harris T.O., and Hepworth C. Loss, humiliation and entrapment among women developing depression: a patient and non-patient comparison. Psychol. Med. 25 (1995) 7-21
17. Chou P.B., and Morse C.A. Understanding premenstrual syndrome from a Chinese medicine perspective. J. Altern. Complement. Med. 11 2 (2005) 355-361
18. Dickerson L.M., Mazyck P.J., and Hunter M.H. Premenstrual syndrome. Am. Fam. Phys. 67 (2003) 1743-1751
19. Du M., Flanigan V., and Ma Y. Simultaneous determination of polyamines and catecholamines in PC-12 tumor cell extracts by capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis 25 (2004) 1496-1502
20. Endicott J., Amsterdam J., Eriksson E., Frank E., Freeman E., Hirschfeld R., Ling F., Parry B., Pearlstein T., Rosenbaum J., Rubinow D., Schmidt P., Severino S., Steiner M., Stewart D.E., and Thys-Jacobs S. Is premenstrual dysphoric disorder a distinct clinical entity?. J. Women's Health Gend.-Based Med. 8 (1999) 663-679
21. Eriksson E., Andersch B., Ho H.P., Landen M., and Sundblad C. Diagnosis and treatment of premenstrual dysphoria. J. Clin. Psychiatry 63 7 (2002) 16-23
22. Facchinetti F., Genazzani A.D., Martignoni E., Fioroni L., Nappi G., and Genazzani A.R. Neuroendocrine changes in luteal function in patients with premenstrual syndrome. J. Clin. Endocrinol. Metab. 76 (1993) 1123-1127
23. Girdler S.S., Thompson K.S., Light K.C., Leserman J., and Pedersen C.A. Historical sexual abuse and current thyroid axis profiles in women with premenstrual dysphoric disorder. Psychosom. Med. 66 3 (2004) 403-410
24. Gromoll J., Brocker M., Derwahl M., and Hoppner W. Detection of mutations in glycoprotein hormone receptors. Methods 21 (2000) 83-97
25. Gromoll J., Wistuba J., Terwort N., Godmann M., Muller T., and Simoni M. A new ubclass of the luteinizing hormone/chorionic gonadotropin receptor lacking exon 10 messenger RNA in the New World monkey (Platyrrhini) lineage. Biol. Reprod. 69 (2003) 75-80
26. Gurguis G.N., Yonkers K.A., Phan S.P., Blakeley J.E., Williams A., and Rush A.J. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. Biol. Psychiatry 44 (1998) 600-609
27. Gurguis G.N., Yonkers K.A., Blakeley J.E., Phan S.P., and Rush J. Adrenergic receptors in premenstrual dysphoric disorder: II. Neutrophil 2-adrenergic receptors: G3 protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity. Psychiatry Res. 79 (1998) 31-42
28. Halbreich U. Gonadal hormones and antihormone, serotonin and mood. Psychopharmacol. Bull. 26 (1990) 291-295
29. Halbreich U. The etiology, biology, and evolving pathology of premenstrual. Psychoneuroendocrinology 28 (2003) 55-99
30. Halbreich U., Endicott J., and Lesser J. The clinical diagnosis and classification of premenstrual changes. Can. J. Psychiatry 30 7 (1985) 489-497
31. Halbreich U., Piletz J.E., Carson S., Halaris A., and Rojansky N. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol. Psychiatry 34 (1993) 676-686
32. Haskett R.F., Steiner M., and Carroll B.J. A psychoendocrine study of premenstrual tension syndrome. A model for endogenous depression. J. Affect. Disord. 6 2 (1984) 191-199
33. Ho H.P., Olsson M., Westberg L., Melke J., and Eriksson E. The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability. Neuropsychopharmacology 24 5 (2001) 502-510
34. Jianzhen K., Xue-Bo Y., Xiurong Y., and Erkang W. Electrochemiluminescence quenching as an indirect method for detection of dopamine and epinephrine with capillary electrophoresis. Electrophoresis 26 (2005) 1732-1736
35. Jones B.J., and Blackburn T.P. The medical benefit of 5-HT research. Pharmacol. Biochem. Behav. 71 4 (2002) 555-568
36. Kouri E.M., and Halbreich U. State and trait serotonergic abnormalities in women with dysphoric premenstrual syndromes. Psychopharmacol. Bull. 33 (1997) 767-770
37. Lande'n M., and Eriksson E. How does premenstrual dysphoric disorder related to depression and anxiety disorders?. Depress. Anxiety 17 (2003) 122-129
38. Liu Y.X., Gao F., Wei P., Chen X.L., Gao H.J., Zou R.J., Siao L.J., Xu F.H., Feng Q., Liu K., and Hu Z.Y. Involvement of molecules related to angiogenesis, proteolysis and apoptosis in implantation in rhesus monkey and mouse. Contraception 71 4 (2005) 249-262
39. Mann J.J., Arango V., Marzuk P.M., Theccanat S., and Reis D.J. Evidence for the 5HT hypothesis of suicide: a review of post-mortem studies. Br. J. Psychiatry 185 (1989) 7-14
40. Moller S.E. Serotonin, carbohydrates, and atypical depression. Pharmacol. Toxicol. 71 1 (1992) 61-71
41. Nagle C.A., and Denari J.H. Reproduction in New World primates, the cebus monkeys (Cebus apella), new models in medical sciences (1983), MTP Press Ltd. International Medical Publishers, Lancaster/Boston/The Hague 39-67
42. Ortiz R.E., Ortiz A.C., Gajardo G., Zepeda A.J., Parraguez V.H., Ortiz M.E., and Croxatto H.B. Cytologic, hormonal and ultrasonographic correlates of the menstrual cycle of the New World monkey Cebus paella. Am. J. Primatol. 66 3 (2005) 233-244
43. Qiao M., Zhang H., Kun J., Youfeng F., Jingyi W., Shuzheng D., Luhua Y., and Tianhong Ch. Studies on the underlying mechanism by which Jingqianshu granule cured 403 premenstrual dysphoric syndrome liver-in patients by making a randomized double-blind clinic survey. J. Chin. New Drugs 11 5 (2002) 182-201
44. Qiao M., Zhang H., and Wang H. Establishing "the emotion evaluation table of female experiment macaque" and mensuration of its reliability and validity. J. Zhejiang Univ. Tradit. Chin. Med. 2 30 (2006) 176-180
45. Qiao, Mingqi, Zhang, Huiyun, Ma, Yuexiang, Yu., Yanhong, in press. The expression level of 5-HT1A receptor gen in different encephalic region of rat model mimicking premenstrual depression symptom. Tradit. Chin. Med. Mod.
46. Rojansky N., Halbreich U., Zander K., Barkai A., and Goldstein S. Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol. Obstet. Investig. 31 (1991) 146-152
47. Schins A., Hamulyak K., Scharpe S., Lousberg R., Van Melle J., Crijns H., and Honig A. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sci. 24 (2004) 637-650 (76, 6)
48. Seippel L., and Torbjo B. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. J. Clin. Endocrinol. Metab. 83 6 (1998) 1988-1992
49. Sengupta J., Dhawan L., Lalitkumar P.G., and Ghosh D. A multiparametric study of the action of mifepristone used in emergency contraception using the rhesus monkey as a primate model. Contraception 68 6 (2003) 453-469
50. Shi Z., Qiao M., Zhang H., and Liu J. Preliminary investigation on the change pattern in female rhesus monkeys (Macaca mulatta) behavior, feature and sex hormone during menolipsis phase. Chin. J. Comp. Med. 2 13 (2003) 80-83
51. Shively C.A. Social subordination, stress, behavior, and central monoaminergic function in female cynomolgus monkeys. Biol. Psychiatry 44 (1998) 882-891
52. Shively C.A., and Kaplan J.R. Stability of social status rankings of female cynomolgus monkeys, of varying reproductive condition, in different social groups. Am. J. Primatol. 23 (1991) 239-245
53. Shively C.A., Laber-Laird K., and Anton R.F. Behavior and physiology of social stress and depression in female cynomolgus monkeys. Biol. Psychiatry 41 (1997) 871-882
54. Shively C.A., Williams J.K., Laber-Laird K., and Anton R.F. Depression and coronary artery atherosclerosis and reactivity in female cynomolgus monkeys. Psychosom. Med. 64 5 (2002) 699-706
55. Smith S.S., Ruderman Y., HuaGong Q., and Gulinello M. Effects of a low dose of ethanol in an animal model of premenstrual anxiety. Alcohol 33 1 (2004) 41-49
56. Spinelli M.G. Depression and hormone replacement therapy. Clin. Obstet. Gynecol. 47 2 (2004) 428-436
57. Spinelli M.G. Neuroendocrine effects on mood. Rev. Endocr. Metab. Disord. 6 2 (2005) 109-115
58. Steiner M. Premenstrual syndromes. Annu. Rev. Med. 48 (1997) 447-455
59. Steiner M. Recognition of PMDD and its treatment. Lancet 356 (2000) 1126-1127
60. Sundstrom P.I., Smith S., and Gulinello M. GABA receptors, progesterone and premenstrual dysphoric disorder. Arch. Women Ment. Health 6 1 (2003) 23-41
61. Sundström P.I., Smith S., and Gulinello M. GABA receptors, progesterone and premenstrual dysphoric disorder. Arch. Women Ment. Health 6 (2003) 23-41
62. Suomi S.J., Eisle C.D., Grady S.A., and Harlow H.F. Depressive behavior in adult monkeys following separation from family environment. J. Abnorm. Psychology 84 (1975) 576-578
63. Van Praag H.M. Neuroendocrine disorders in depressions and their significance for the monoamine hypothesis of depression. Acta Psychiatr. Scand. 57 (1978) 389-404
64. Vujovic S., Zidverc J., Stojanovic M., Penezic Z., Ivovic M., Dukic V., and Drezgic M. Drospirenone in the treatment of severe premenstrual cerebral edema in a woman with antiphospholipid syndrome, lateral sinus thrombosis, situs in versus and epileptic seizures. Gynecol. Endocrinol. 21 5 (2005) 243-247
65. Wang H., Xue L., Zhang H., and Qiao M. Change on the expression, behavior and level of neurotransmitters in monkeys mode premenstrual dysphoric syndrome models. Pharmacol. Clin. Tradit. Chin. Med. 20 (2004) 30-38
66. Watson S.L., Shively C.A., Kaplan J.R., and Line S.W. Effects of chronic social separation on cardiovascular disease risk factors in female cynomolgus monkeys. Atherosclerosis 137 (1998) 259-266
67. Woller M.J., McDonald J.K., Reboussin D.M., and Terasawa E. Neuropeptide Y is a neuromodulator of pulsatile luteinizing hormone-releasing hormone release in the gonadectomized rhesus monkey. Endocrinology 130 (1992) 2333-2342
68. Wuttke W., Jarry H., Christoffel V., Spengler B., and Seidlova-Wuttke D. Chaste tree (Vitex agnus-castus)-pharmacology and clinical indications. Phytomedicine 10 4 (2003) 348-357
69. Xiao E., Xia-Zhang L., and Ferin M. Stress and the menstrual cycle: short- and long-term response to a five-day endotoxin challenge during the luteal phase in the rhesus monkey. J. Clin. Endocrinol. Metab. 84 (1999) 623-626